Literature DB >> 16041226

Hormonal status, fertility, and pregnancy before and after bariatric surgery.

Rita Harrison Raymond1.   

Abstract

At the present time, the exact etiology and developmental course of obesity in many individuals is still being debated. The majority of healthcare professionals are in agreement, however, that morbidly obese persons are at risk for a wide range of health problems, both before and after bariatric surgery. Obesity is, unfortunately, a condition in which the disease as well as the available treatments have the potential to cause serious alterations in health status. The average candidate for bariatric surgery has experienced decades of varying degrees of obesity as well as multiple failed dietary and medication regimens. As a result of almost continual physiologic instability, these individuals typically are subject to a wide range of hormonal imbalances. Since the majority of persons who are obese, and those seeking bariatric surgery, are women, it is important for healthcare providers to understand how these hormonal fluctuations can have a devastating impact on sexual and reproductive function. Although the research to date has been limited, studies have demonstrated changes in fertility, contraceptive response, and pregnancy outcomes in obese women, as well as obese women who undergo bariatric surgery. As morbid obesity continues to increase in incidence in the female population, greater numbers of women will seek bariatric surgery, and, as a consequence, experience some of the untoward effects shown to date. Addressing the concerns of these patients, both before and after surgery, will continue to be a complex and challenging task.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041226     DOI: 10.1097/00002727-200507000-00005

Source DB:  PubMed          Journal:  Crit Care Nurs Q        ISSN: 0887-9303


  1 in total

1.  Pregnancy after bariatric surgery: 39 pregnancies follow-up in a multidisciplinary team.

Authors:  Flavia Emilia Bebber; Jacqueline Rizzolli; Daniela Schaan Casagrande; Marcelo Tadday Rodrigues; Alexandre Vontobel Padoin; Claudio Corá Mottin; Giuseppe Repetto
Journal:  Obes Surg       Date:  2011-10       Impact factor: 4.129

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.